Washington Healthcare Update - April 2022 #3 | McGuireWoods Consulting
This Week in Washington: White House Releases National Drug Control Strategy...
Stay updated with breaking news from Fee Agreements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This Week in Washington: White House Releases National Drug Control Strategy...
It’s been a good week for biotech trials. Nkarta Therapeutics, led by BIO’s Chair, announced positive data in two trials of its natural killer cell therapies targeting advanced blood cancer, and gene edited mosquitoes “behaved as planned” in the first trial in the Florida Keys. (632 words, 3 minutes, 9 seconds)
Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...
A bipartisan agreement on a $10 billion fully paid-for COVID-relief package was reached by the Senate, but the deal was sidelined. 2023 MA and Part D rate notice that MA plans will see an estimated 8.5% total average increase in payments next year.